|
PPHLN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.38230005219953E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06960000026513E-07 |
| Normal-vs-Stage2 |
3.984100E-03 |
| Normal-vs-Stage3 |
1.424280E-03 |
| Normal-vs-Stage4 |
2.563600E-03 |
| Stage1-vs-Stage2 |
7.265000E-01 |
| Stage1-vs-Stage3 |
7.352000E-01 |
| Stage1-vs-Stage4 |
3.794800E-01 |
| Stage2-vs-Stage3 |
9.656200E-01 |
| Stage2-vs-Stage4 |
5.776400E-01 |
| Stage3-vs-Stage4 |
5.526400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.49229999865963E-08 |
| Normal-vs-AfricanAmerican |
2.6207000003442E-07 |
| Normal-vs-Asian |
8.683700E-02 |
| Caucasian-vs-AfricanAmerican |
5.604300E-02 |
| Caucasian-vs-Asian |
7.520600E-01 |
| AfricanAmerican-vs-Asian |
7.477600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47209999745712E-08 |
| Normal-vs-Female |
4.52060000544208E-08 |
| Male-vs-Female |
2.618200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.355900E-04 |
| Normal-vs-Extreme_Weight |
1.77384999999752E-05 |
| Normal-vs-Obese |
2.37530000002373E-06 |
| Normal-vs-Extreme_Obese |
5.942200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.807000E-01 |
| Normal_Weight-vs-Obese |
8.574600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.317900E-02 |
| Extreme_Weight-vs-Obese |
4.060800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.237550E-01 |
| Obese-vs-Extreme_Obese |
6.655500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85165999999626E-05 |
| Normal-vs-Age(41-60Yrs) |
2.6988999923816E-10 |
| Normal-vs-Age(61-80Yrs) |
1.7355100000005E-05 |
| Normal-vs-Age(81-100Yrs) |
9.141900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.162980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.150100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.110100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.290300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.228200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.472000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17680309941193E-11 |
| Normal-VS-Type2 PRCC |
2.072500E-02 |
| Normal-VS-KIRP CIMP |
1.477140E-03 |
| Normal-VS-Unclassified PRCC |
2.230200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.49569999999766E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.418400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.732800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.084480E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.013500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.867400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.572130E-02 |
| Normal-vs-N1 |
6.05109999999298E-05 |
| Normal-vs-N2 |
1.740830E-01 |
| N0-vs-N1 |
2.080300E-03 |
| N0-vs-N2 |
1.078350E-01 |
| N1-vs-N2 |
9.830800E-01 |
|
|
